Spontaneous acetylcholine release in mammalian neuromuscular junctions

The American Journal of Physiology
A S Losavio, S Muchnik

Abstract

Spontaneous secretion of the neurotransmitter acetylcholine in mammalian neuromuscular synapsis depends on the Ca2+ content of nerve terminals. The Ca2+ electrochemical gradient favors the entry of this cation. We investigated the possible involvement of three voltage-dependent Ca2+ channels (VDCC) (L-, N-, and P/Q-types) on spontaneous transmitter, release at the rat neuromuscular junction. Miniature end-plate potential (MEPP) frequency was clearly reduced by 5 microM nifedipine, a blocker of the L-type VDCC, and to a lesser extent by the N-type VDCC blocker, omega-conotoxin GVIA (omega-CgTx, 5 microM). On the other hand, nifedipine and omega-CgTx had no effect on K(+)-induced transmitter secretion. omega-Agatoxin IVA (100 nM), a P/Q-type VDCC blocker, prevents acetylcholine release induced by K+ depolarization but failed to affect MEPP frequency in basal conditions. These results suggest that in the mammalian neuromuscular junction Ca2+ enters nerve terminals through at least three different channels, two of them (L- and N-types) mainly related to spontaneous acetylcholine release and the other (P/Q-type) mostly involved in depolarization-induced neurotransmitter release. Ca(2+)-binding molecule-related spontaneous release ap...Continue Reading

References

Apr 28, 1978·Annals of the New York Academy of Sciences·M P BlausteinN K Kendrick
Feb 15, 1979·European Journal of Pharmacology·S J Publicover, C J Duncan
Mar 1, 1992·Cell Calcium·M D Stern
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·O D UchitelR Llinás
Sep 1, 1991·Trends in Pharmacological Sciences·R W TsienW A Horne
Jan 1, 1990·Annual Review of Cell Biology·R W Tsien, R Y Tsien
Mar 31, 1987·European Journal of Pharmacology·K KoyanoS Sakakibara
Jul 3, 1973·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·R Miledi
Nov 1, 1968·The Journal of Physiology·Z L BliochV A Nenashev
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·R Rahamimoff, E Alnaes
Mar 15, 1984·Nature·L M Kerr, D Yoshikami
Jun 1, 1995·The New England Journal of Medicine·V A LennonE H Lambert
Jun 1, 1994·Current Opinion in Neurobiology·E W McCleskey

❮ Previous
Next ❯

Citations

Jun 6, 2003·Headache·Mustafa Ertas, M Baris Baslo
Mar 17, 2004·Lasers in Surgery and Medicine·Renata Amadei NicolauJosep Tomàs
May 3, 2012·The Neurologist·Suber DikiciAbdulkadir Kocer
Jul 13, 2017·Journal of Neuroscience Research·Courtney L Williams, Stephen M Smith
Feb 13, 2018·Journal of Neuroscience Research·Juan F GuarracinoAdriana S Losavio
May 8, 2002·The European Journal of Neuroscience·Shu-Ming HuangKenji Kuba
Jan 1, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Monika Cecilija ŽužekRobert Frangež
Feb 14, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Víctor Cilleros-MañéMaria Angel Lanuza
Dec 16, 1998·The Journal of Physiology·M D Rosato Siri, O D Uchitel
Apr 7, 2004·British Journal of Pharmacology·Silvana De LorenzoAdriana Losavio
Sep 25, 2017·Acta neurologica Belgica·Halil Ay, Özlem Ethemoğlu
Dec 13, 2019·Proceedings of the National Academy of Sciences of the United States of America·Yue ShiPer-Olof Berggren
Oct 22, 2017·Toxicon : Official Journal of the International Society on Toxinology·Phillip H BeskePatrick M McNutt
Jul 18, 2008·International Journal of Oral and Maxillofacial Surgery·Leonidas ManolopoulosThomas P Nikolopoulos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.